Wanbury Limited

BSE: 524212 NSE: BE : WANBURY
Wanbury Limited - pharma in New Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN L51900MH1988PLC048455 Incorporated 11 August 1988 ROC Mumbai HQ New Mumbai, Maharashtra, India
Active Listed - NSE: BE : WANBURY · BSE: 524212 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹650.27 Cr
▲ 8.47% YoY
EBITDA · FY 2026
₹107.69 Cr
▲ 34.93% YoY
Net profit · FY 2026
₹66.13 Cr
▲ 116.62% YoY
Authorised capital
₹50 Cr
Registered with MCA
Paid-up capital
₹34.89 Cr
Issued & subscribed
Open charges
₹255 Cr
Satisfied ₹722.25 Cr
Company age
38 yrs
Est. 1988
Employees · EPFO
742
Latest available

About Wanbury Limited

Data last updated: 22 December 2025

Wanbury Limited is a public limited company based in New Mumbai, Maharashtra, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 11 August 1988, the company has been in operation for over 38 years.

Registered with ROC Mumbai under CIN L51900MH1988PLC048455. Listed on BSE: 524212 and NSE: BE : WANBURY.

Capital: an authorised share capital of ₹50 Cr and a paid-up capital of ₹34.89 Cr. Formerly known as Pearl Organics Ltd and Pearl Organics Pvt Ltd. It is led by directors including Manojkumar Khubchand Gursahani and Chandran Krishnamoorthy.

Last AGM: 18 September 2025. Financial statements filed for year ended 31 March 2025. Office: Sector 30, New Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹603.01 Cr, a growth of 4% compared to the previous year.

The company has a workforce of approximately 742 employees as per the latest available data.

The company is associated with 1 brand - Wanbury Limited. As per MCA filings, the company has open charges of ₹255 Cr and satisfied charges of ₹722.25 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website wanbury.com.

Company Details of Wanbury Limited
CIN L51900MH1988PLC048455
Registration Number 048455
Incorporation Date 11 August 1988
ROC Mumbai
Listing Status Listed (BSE: 524212, NSE: BE : WANBURY)
Company Status Active
Date of Last AGM 18 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Chandran Krishnamoorthy Whole-Time Director Mohan Kumar Rayana Whole-Time Director Manojkumar Khubchand Gursahani Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    wanbury.com
  • Social Media
    **************
  • Registered Address
    Bsel Tech Park 'B; Wing 10Th Floor Sector 30A Opp.Vashi Railway Station V, Ashi, New Mumbai, Maharashtra, India – 400703
  • Industry
    Pharma, API Manufacturers
Company report
Wanbury Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Wanbury Limited report

Financials, compliance, directors, charges, ownership and filings for Wanbury Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Wanbury Limited

Wanbury Limited has undergone 3 name changes throughout its history. The company was previously known as Pearl Organics Ltd, Pearl Organics Pvt Ltd, and Pearl Distributors Pvt Ltd. The current legal name is Wanbury Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Wanbury Limited Current
Pearl Organics Ltd Previous
Pearl Organics Pvt Ltd Previous
Pearl Distributors Pvt Ltd Previous

Associated Brands with Wanbury Limited

Wanbury Limited operates one associated brand: Wanbury Limited. These brands represent Wanbury Limited's diversified market presence and brand portfolio.

Brand Description Website
Wanbury Limited
Anti-diabetic drugs and active pharmaceutical ingredients are manufactured. wanbury.com

Competitors & Alternatives of Wanbury Limited

Brands and companies operating in the same space as Wanbury Limited include Concord Biotech, BDR Pharmaceuticals Internationals, Almac Group and 7 more.

Competitor Description Location Founded
Concord Biotech Concord Biotech APIs and enzymes are manufactured through fermentation by the CDMO. Ahmedabad, India, India 2000
BDR Pharmaceuticals Internationals BDR Pharmaceuticals Internationals APIs and finished products are developed and manufactured. Mumbai, India, India 2003
Almac Group Almac Group Integrated CDMO services for biopharma R&D and manufacturing are offered. Craigavon, United Kingdom, United Kingdom 2001
Indoco Remedies Indoco Remedies APIs manufacturing and formulation services are provided in therapeutic segments. Mumbai, India, India 1947
Pharmaceutics International Pharmaceutics International Pharmaceutical dosage forms are manufactured by this CDMO. Hunt Valley, United States, United States 1994
Aurobindo Pharma Aurobindo Pharma Generic biocatalytic solutions are provided for pharmaceutical applications. Hyderabad, India, India 1986
Seqens Seqens Contract manufacturing services for small molecules and peptides are provided. Ecully, France, France 2003
Asymchem Asymchem APIs and peptides are developed and manufactured by Asymchem. Morrisville, United States, United States 1995
Aptuit Aptuit Contract research and development services for small molecules are offered. Greenwich, United States, United States 2004
Continuus Pharma Continuus Pharma MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development Woburn, United States, United States 2012

Business Activity of Wanbury Limited

Wanbury Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Auditor Details of Wanbury Limited

Wanbury Limited is audited by M/s. Kapoor & Parekh Associates (ICAI peer reviewed, certificate valid till 2028-11-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
M/s. Kapoor & Parekh Associates (ICAI peer reviewed, certificate valid till 2028-11-30) FY 2026 Declaration of unmodified opinion

Board of Directors of Wanbury Limited

Wanbury Limited is currently managed by 8 directors, with 24 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Manojkumar Khubchand Gursahani
Also directs: Aison Technology Llp
Director 08 Jan 2025 1 Years 6 Months Current
Chandran Krishnamoorthy Whole-Time Director 01 Sep 2010 15 Years 10 Months Current
Mridul Sumanlal Mehta
Also directs: Valueadd Advisors Private Limited
Director 12 Aug 2024 1 Years 10 Months Current
Mohan Kumar Rayana
Also directs: Akkadian Trading And Marketing Private Limited, Gunbow Infotech And Datacom Private Limited
Whole-Time Director 21 Aug 2023 2 Years 10 Months Current
Pallavur Sankar Dass Vaidyanathan
Also directs: Futura Surgicare Private Limited, Suturemate Technologies Private Limited, Suture Planet Private Limited
Director 08 Jan 2025 1 Years 6 Months Current
Anupama Vaidya
Also directs: Platinumone Business Services Limited, John Cockerill India Limited
Director 17 Mar 2022 4 Years 3 Months Current
Showing 6 of 8 current directors. View all directors

Financials of Wanbury Limited FY 2026 filings available

Wanbury Limited reported revenue of ₹650.27 Cr (up 8.47% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹650.27 Cr ▲ 8.47%
Profit · FY 2026
₹66.13 Cr ▲ 116.62%
EBITDA · FY 2026
₹107.69 Cr ▲ 34.93%
Revenue₹ Cr · Standalone0250500750FY 2020: ₹367 Cr367FY 2020FY 2021: ₹393 Cr · +6.8% YoY393+6.8%FY 2021FY 2022: ₹511 Cr · +30.2% YoY511+30.2%FY 2022FY 2023: ₹500 Cr · -2.3% YoY500-2.3%FY 2023FY 2024: ₹576 Cr · +15.2% YoY576+15.2%FY 2024FY 2025: ₹600 Cr · +4.1% YoY600+4.1%FY 2025FY 2026: ₹650 Cr · +8.5% YoY650+8.5%FY 2026
Net Profit₹ Cr · Standalone-50050100FY 2020: ₹0 Cr0.2FY 2020FY 2021: ₹13 Cr (loss) · -6145.9% YoY-12.6FY 2021FY 2022: ₹81 Cr · +746.3% YoY81.5+746.3%FY 2022FY 2023: ₹10 Cr (loss) · -112.8% YoY-10.4FY 2023FY 2024: ₹30 Cr · +392.4% YoY30.4+392.4%FY 2024FY 2025: ₹31 Cr · +0.4% YoY30.5+0.4%FY 2025FY 2026: ₹66 Cr · +116.6% YoY66.1+116.6%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0100200Q1'25: ₹131 Cr · -10.4% YoY131-10.4%Q1'25Q2'25: ₹161 Cr · +11.6% YoY161+11.6%Q2'25Q3'25: ₹133 Cr · -8.3% YoY133-8.3%Q3'25Q4'25: ₹172 Cr · +23.4% YoY172+23.4%Q4'25Q1'26: ₹163 Cr · +24.5% YoY163+24.5%Q1'26Q2'26: ₹160 Cr · -0.7% YoY160-0.7%Q2'26Q3'26: ₹162 Cr · +21.7% YoY162+21.7%Q3'26Q4'26: ₹165 Cr · -4.3% YoY165-4.3%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹650.27 Cr ₹599.51 Cr ₹575.65 Cr ₹499.65 Cr ₹511.19 Cr ₹392.52 Cr ₹367.45 Cr
Other Income ₹93.72 Lakh ₹3.49 Cr ₹2.99 Cr ₹91.32 Lakh ₹1.51 Cr ₹2.4 Cr ₹1.14 Cr
Total Income ₹651.21 Cr ₹603.01 Cr ₹578.64 Cr ₹500.56 Cr ₹512.69 Cr ₹394.92 Cr ₹368.59 Cr
Cost of Materials Consumed ₹272.9 Cr ₹277.88 Cr ₹289.22 Cr ₹257.48 Cr ₹304.93 Cr ₹213.7 Cr ₹146.42 Cr
Purchases of Stock-in-Trade ₹16.62 Cr ₹15.08 Cr ₹17.3 Cr ₹15.98 Cr ₹20.14 Cr ₹10.65 Cr ₹23.33 Cr
Changes in Inventories -₹13 Cr ₹1.51 Cr -₹3.89 Cr ₹29.13 Cr -₹24.79 Cr -₹7.2 Cr ₹5.99 Cr
Employee Benefit Expense ₹119.64 Cr ₹104.24 Cr ₹86.92 Cr ₹81 Cr ₹74.81 Cr ₹64.15 Cr ₹67.48 Cr
Finance Costs ₹29.98 Cr ₹36.95 Cr ₹29.18 Cr ₹21.39 Cr ₹20.61 Cr ₹23.07 Cr ₹32.87 Cr
Depreciation & Amortisation ₹14.31 Cr ₹13.31 Cr ₹13.03 Cr ₹12.38 Cr ₹11.45 Cr ₹9.75 Cr ₹9.68 Cr
Other Expenses ₹147.37 Cr ₹124.49 Cr ₹116.09 Cr ₹92.88 Cr ₹100.77 Cr ₹93.2 Cr ₹100.79 Cr
Total Expenses ₹587.8 Cr ₹573.46 Cr ₹547.86 Cr ₹510.25 Cr ₹507.93 Cr ₹407.33 Cr ₹386.56 Cr
Profit Before Exceptional Items & Tax ₹63.41 Cr ₹29.55 Cr ₹30.78 Cr -₹9.69 Cr ₹4.76 Cr -₹12.41 Cr -₹17.97 Cr
Exceptional Items -₹3.6 Cr ₹0 ₹0 -₹59.38 Lakh ₹76.37 Cr ₹0 ₹82.64 Cr
Profit Before Tax ₹59.8 Cr ₹29.55 Cr ₹30.78 Cr -₹10.29 Cr ₹81.13 Cr -₹12.41 Cr ₹64.67 Cr
Total Tax Expense -₹6.33 Cr -₹97.94 Lakh ₹38.1 Lakh ₹10.9 Lakh -₹34.62 Lakh ₹20 Lakh ₹64.46 Cr
Net Profit ₹66.13 Cr ₹30.53 Cr ₹30.4 Cr -₹10.4 Cr ₹81.47 Cr -₹12.61 Cr ₹20.85 Lakh
Other Comprehensive Income -₹54.96 Lakh -₹36.85 Lakh -₹70.94 Lakh ₹5.04 Lakh ₹1.12 Cr -₹44.11 Lakh -₹45.99 Lakh
Total Comprehensive Income ₹65.59 Cr ₹30.16 Cr ₹29.69 Cr -₹10.35 Cr ₹82.6 Cr -₹13.05 Cr -₹25.14 Lakh
EBITDA (computed) ₹107.69 Cr ₹79.81 Cr ₹72.99 Cr ₹24.08 Cr ₹36.82 Cr ₹20.42 Cr ₹24.59 Cr
Basic EPS ₹20.55 ₹9.32 ₹9.29 ₹-3.00 ₹1.59 ₹-5.04 ₹26.90
Diluted EPS ₹19.49 ₹8.98 ₹9.18 ₹-3.00 ₹1.58 ₹-5.04 ₹26.90
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹517.67 Cr ₹413.92 Cr ₹343.49 Cr ₹302.25 Cr
Non-current Assets ₹279.11 Cr ₹220.47 Cr ₹184.21 Cr ₹179.74 Cr
Current Assets ₹238.56 Cr ₹193.44 Cr ₹159.29 Cr ₹120.54 Cr
Property, Plant & Equipment ₹226.51 Cr ₹189.69 Cr ₹149.02 Cr ₹151.5 Cr
Inventories ₹50.63 Cr ₹37.68 Cr ₹36.02 Cr ₹21.99 Cr
Trade Receivables ₹143.28 Cr ₹114.16 Cr ₹89.44 Cr ₹67.98 Cr
Cash & Equivalents ₹1.61 Cr ₹4.06 Cr ₹3.4 Cr ₹1.46 Cr
Equity (Net Worth) ₹144.45 Cr ₹59.27 Cr ₹27.94 Cr -₹7.26 Cr
Equity Share Capital ₹34.94 Cr ₹32.77 Cr ₹32.75 Cr ₹32.71 Cr
Borrowings (Non-current) ₹147.15 Cr ₹160.29 Cr ₹82 Cr ₹0
Borrowings (Current) ₹68.3 Cr ₹12.94 Cr ₹27.95 Cr ₹64.14 Cr
Total Debt (computed) ₹215.45 Cr ₹173.23 Cr ₹109.95 Cr ₹64.14 Cr
Current Liabilities ₹201.04 Cr ₹174.61 Cr ₹214.11 Cr ₹293.19 Cr
Total Liabilities ₹373.22 Cr ₹354.65 Cr ₹315.55 Cr ₹309.5 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹31.53 Cr ₹26.1 Cr ₹4.02 Cr ₹19.8 Cr ₹37.56 Cr
Investing Cash Flow -₹56.4 Cr -₹51.17 Cr -₹16.63 Cr -₹8.84 Cr ₹58.65 Lakh
Financing Cash Flow ₹22.42 Cr ₹25.73 Cr ₹14.55 Cr -₹31.99 Cr -₹25.62 Cr
Capital Expenditure ₹59.06 Cr ₹49.03 Cr ₹0 ₹0 ₹0
Free Cash Flow (computed) -₹27.53 Cr -₹22.93 Cr ₹4.02 Cr ₹19.8 Cr ₹37.56 Cr
Dividends Paid ₹0 ₹0 ₹3.14 Cr ₹0 ₹0
Net Change in Cash -₹2.45 Cr ₹66.04 Lakh ₹1.94 Cr -₹21.03 Cr ₹12.53 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹164.58 Cr ₹162.45 Cr ₹160.06 Cr ₹163.18 Cr ₹172 Cr ₹133.45 Cr ₹161.19 Cr ₹131.11 Cr ₹139.41 Cr ₹145.5 Cr ₹144.46 Cr ₹146.29 Cr
Other Income ₹20.75 Lakh ₹17.83 Lakh ₹20.35 Lakh ₹34.79 Lakh ₹1.84 Cr ₹83.75 Lakh ₹1.63 Cr ₹94.46 Lakh ₹92.52 Lakh ₹69.25 Lakh ₹75.57 Lakh ₹61.66 Lakh
Total Income ₹164.79 Cr ₹162.63 Cr ₹160.26 Cr ₹163.53 Cr ₹173.84 Cr ₹134.29 Cr ₹162.82 Cr ₹132.05 Cr ₹140.33 Cr ₹146.19 Cr ₹145.22 Cr ₹146.9 Cr
Cost of Materials Consumed ₹62.95 Cr ₹66.51 Cr ₹70.66 Cr ₹72.78 Cr ₹75.95 Cr ₹60.91 Cr ₹76.82 Cr ₹64.2 Cr ₹66.87 Cr ₹63.85 Cr ₹75.75 Cr ₹82.75 Cr
Purchases of Stock-in-Trade ₹2.82 Cr ₹6.06 Cr ₹4.64 Cr ₹3.1 Cr ₹3.89 Cr ₹4.71 Cr ₹3.2 Cr ₹3.28 Cr ₹3.98 Cr ₹6.51 Cr ₹3.65 Cr ₹3.17 Cr
Changes in Inventories -₹46.37 Lakh -₹3.77 Cr -₹8.24 Cr -₹53.58 Lakh ₹4.48 Cr -₹3.75 Cr ₹2 Cr -₹1.22 Cr -₹42.22 Lakh ₹46.69 Lakh -₹3.05 Cr -₹88.92 Lakh
Employee Benefit Expense ₹29.68 Cr ₹31.84 Cr ₹29.43 Cr ₹28.69 Cr ₹26.42 Cr ₹26.31 Cr ₹26.35 Cr ₹25.15 Cr ₹20.14 Cr ₹24.63 Cr ₹21.07 Cr ₹21.08 Cr
Finance Costs ₹8.06 Cr ₹7.26 Cr ₹7.12 Cr ₹7.54 Cr ₹9.04 Cr ₹10.17 Cr ₹10.15 Cr ₹7.59 Cr ₹7.46 Cr ₹8.26 Cr ₹7.67 Cr ₹5.79 Cr
Depreciation & Amortisation ₹3.23 Cr ₹3.74 Cr ₹3.7 Cr ₹3.64 Cr ₹3.37 Cr ₹3.32 Cr ₹3.32 Cr ₹3.29 Cr ₹3.28 Cr ₹3.32 Cr ₹3.24 Cr ₹3.18 Cr
Other Expenses ₹39.74 Cr ₹35.13 Cr ₹37.79 Cr ₹34.71 Cr ₹31.63 Cr ₹31.32 Cr ₹32.81 Cr ₹28.73 Cr ₹30.68 Cr ₹28.89 Cr ₹29.69 Cr ₹26.83 Cr
Total Expenses ₹146.01 Cr ₹146.76 Cr ₹145.1 Cr ₹149.93 Cr ₹154.79 Cr ₹133 Cr ₹154.65 Cr ₹131.02 Cr ₹131.98 Cr ₹135.93 Cr ₹138.03 Cr ₹141.91 Cr
Profit Before Exceptional Items & Tax ₹18.77 Cr ₹15.87 Cr ₹15.16 Cr ₹13.61 Cr ₹19.05 Cr ₹1.29 Cr ₹8.17 Cr ₹1.04 Cr ₹8.35 Cr ₹10.26 Cr ₹7.19 Cr ₹4.99 Cr
Exceptional Items -₹3.6 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹15.17 Cr ₹15.87 Cr ₹15.16 Cr ₹13.61 Cr ₹19.05 Cr ₹1.29 Cr ₹8.17 Cr ₹1.04 Cr ₹8.35 Cr ₹10.26 Cr ₹7.19 Cr ₹4.99 Cr
Total Tax Expense -₹6.53 Cr ₹10.61 Lakh -₹1.93 Lakh ₹11.53 Lakh -₹1.2 Cr ₹7.44 Lakh ₹14.86 Lakh ₹0 ₹27.21 Lakh -₹1.72 Lakh -₹17.64 Lakh ₹30.24 Lakh
Net Profit ₹21.7 Cr ₹15.76 Cr ₹15.18 Cr ₹13.49 Cr ₹20.26 Cr ₹1.22 Cr ₹8.02 Cr ₹1.04 Cr ₹8.08 Cr ₹10.27 Cr ₹7.36 Cr ₹4.69 Cr
Other Comprehensive Income -₹17.32 Lakh -₹19.78 Lakh ₹3.61 Lakh -₹21.47 Lakh ₹4.66 Lakh -₹13.83 Lakh -₹42,000 -₹27.26 Lakh -₹46.92 Lakh ₹3.78 Lakh ₹38.89 Lakh -₹66.69 Lakh
Total Comprehensive Income ₹21.53 Cr ₹15.56 Cr ₹15.22 Cr ₹13.28 Cr ₹20.3 Cr ₹1.08 Cr ₹8.01 Cr ₹76.48 Lakh ₹7.61 Cr ₹10.31 Cr ₹7.75 Cr ₹4.02 Cr
EBITDA (computed) ₹30.06 Cr ₹26.86 Cr ₹25.98 Cr ₹24.79 Cr ₹31.47 Cr ₹14.78 Cr ₹21.64 Cr ₹11.92 Cr ₹19.09 Cr ₹21.84 Cr ₹18.1 Cr ₹13.96 Cr
Basic EPS ₹7.33 ₹4.52 ₹4.58 ₹4.12 ₹6.18 ₹0.38 ₹2.44 ₹0.32 ₹2.47 ₹3.14 ₹2.25 ₹1.43
Diluted EPS ₹6.34 ₹4.51 ₹4.58 ₹3.95 ₹5.98 ₹0.35 ₹2.44 ₹0.31 ₹2.37 ₹3.14 ₹2.25 ₹1.43
Latest 12 quarters shown of 25 on record.
Metrics FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹599.51 Cr ₹575.65 Cr ₹499.65 Cr ₹511.19 Cr ₹392.52 Cr ₹367.45 Cr
Other Income ₹3.49 Cr ₹2.99 Cr ₹91.32 Lakh ₹1.51 Cr ₹2.4 Cr ₹1.14 Cr
Total Income ₹603.01 Cr ₹578.64 Cr ₹500.56 Cr ₹512.69 Cr ₹394.92 Cr ₹368.59 Cr
Cost of Materials Consumed ₹277.88 Cr ₹289.22 Cr ₹257.48 Cr ₹304.93 Cr ₹213.7 Cr ₹146.42 Cr
Purchases of Stock-in-Trade ₹15.08 Cr ₹17.3 Cr ₹15.98 Cr ₹20.14 Cr ₹10.65 Cr ₹23.33 Cr
Changes in Inventories ₹1.51 Cr -₹3.89 Cr ₹29.13 Cr -₹24.79 Cr -₹7.2 Cr ₹5.99 Cr
Employee Benefit Expense ₹104.24 Cr ₹86.92 Cr ₹81 Cr ₹74.81 Cr ₹64.15 Cr ₹67.48 Cr
Finance Costs ₹36.95 Cr ₹29.18 Cr ₹21.39 Cr ₹20.61 Cr ₹23.07 Cr ₹32.87 Cr
Depreciation & Amortisation ₹13.31 Cr ₹13.03 Cr ₹12.38 Cr ₹11.45 Cr ₹9.75 Cr ₹9.68 Cr
Other Expenses ₹124.49 Cr ₹116.09 Cr ₹92.88 Cr ₹100.77 Cr ₹93.2 Cr ₹100.79 Cr
Total Expenses ₹573.46 Cr ₹547.86 Cr ₹510.25 Cr ₹507.93 Cr ₹407.33 Cr ₹386.56 Cr
Profit Before Exceptional Items & Tax ₹29.55 Cr ₹30.78 Cr -₹9.69 Cr ₹4.76 Cr -₹12.41 Cr -₹17.97 Cr
Exceptional Items ₹0 ₹25.56 Cr -₹59.38 Lakh ₹76.37 Cr ₹0 ₹82.64 Cr
Profit Before Tax ₹29.55 Cr ₹56.34 Cr -₹10.29 Cr ₹81.13 Cr -₹12.41 Cr ₹64.67 Cr
Total Tax Expense -₹97.94 Lakh ₹38.1 Lakh ₹10.9 Lakh -₹34.62 Lakh ₹20 Lakh ₹20.87 Lakh
Net Profit ₹30.53 Cr ₹55.96 Cr -₹10.4 Cr ₹81.47 Cr -₹12.61 Cr ₹64.46 Cr
  attributable to Owners - ₹0 - ₹0 - ₹0
  attributable to NCI - ₹0 - ₹0 - ₹0
Other Comprehensive Income -₹36.85 Lakh -₹70.91 Lakh ₹10.09 Lakh ₹1.1 Cr -₹40.78 Lakh -₹39.33 Lakh
Total Comprehensive Income ₹30.16 Cr ₹55.25 Cr -₹10.29 Cr ₹82.58 Cr -₹13.01 Cr ₹64.07 Cr
EBITDA (computed) ₹79.81 Cr ₹72.99 Cr ₹24.09 Cr ₹36.82 Cr ₹20.42 Cr ₹24.58 Cr
Basic EPS ₹9.32 ₹9.29 ₹-3.00 ₹1.59 ₹-5.04 ₹26.90
Diluted EPS ₹8.98 ₹9.18 ₹-3.00 ₹1.58 ₹-5.04 ₹26.90
Metrics FY 2025 FY 2024 FY 2023
Total Assets ₹413.92 Cr ₹343.49 Cr ₹303.87 Cr
Non-current Assets ₹220.47 Cr ₹184.21 Cr ₹179.74 Cr
Current Assets ₹193.44 Cr ₹159.29 Cr ₹122.16 Cr
Property, Plant & Equipment ₹189.69 Cr ₹149.02 Cr ₹151.5 Cr
Inventories ₹37.68 Cr ₹36.02 Cr ₹21.99 Cr
Trade Receivables ₹114.16 Cr ₹89.44 Cr ₹67.98 Cr
Cash & Equivalents ₹4.06 Cr ₹3.4 Cr ₹1.49 Cr
Equity (Net Worth) ₹59.27 Cr ₹27.94 Cr -₹32.82 Cr
Equity Share Capital ₹32.77 Cr ₹32.75 Cr ₹32.71 Cr
Borrowings (Non-current) ₹160.29 Cr ₹82 Cr ₹0
Borrowings (Current) ₹12.94 Cr ₹27.95 Cr ₹64.14 Cr
Total Debt (computed) ₹173.23 Cr ₹109.95 Cr ₹64.14 Cr
Current Liabilities ₹174.61 Cr ₹214.11 Cr ₹320.37 Cr
Total Liabilities ₹354.65 Cr ₹315.55 Cr ₹336.69 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹26.1 Cr ₹3.98 Cr ₹19.8 Cr ₹37.56 Cr
Investing Cash Flow -₹51.17 Cr -₹16.63 Cr -₹8.84 Cr ₹58.65 Lakh
Financing Cash Flow ₹25.73 Cr ₹14.55 Cr -₹31.99 Cr -₹25.62 Cr
Capital Expenditure ₹49.03 Cr ₹17.42 Cr ₹0 ₹0
Free Cash Flow (computed) -₹22.93 Cr -₹13.45 Cr ₹19.8 Cr ₹37.56 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0
Net Change in Cash ₹66.04 Lakh ₹1.91 Cr -₹21.03 Cr ₹12.53 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24 Q4 FY23 Q3 FY23 Q2 FY23
Revenue from Operations ₹163.18 Cr ₹172 Cr ₹133.45 Cr ₹161.19 Cr ₹131.11 Cr ₹139.41 Cr ₹145.5 Cr ₹144.46 Cr ₹146.29 Cr ₹132.98 Cr ₹125.78 Cr ₹123.96 Cr
Other Income ₹34.79 Lakh ₹1.84 Cr ₹83.75 Lakh ₹1.63 Cr ₹94.46 Lakh ₹92.52 Lakh ₹69.24 Lakh ₹75.57 Lakh ₹61.66 Lakh -₹2.06 Cr ₹25.91 Lakh ₹78.04 Lakh
Total Income ₹163.53 Cr ₹173.84 Cr ₹134.29 Cr ₹162.82 Cr ₹132.05 Cr ₹140.33 Cr ₹146.19 Cr ₹145.22 Cr ₹146.9 Cr ₹130.91 Cr ₹126.04 Cr ₹124.74 Cr
Cost of Materials Consumed ₹72.78 Cr ₹75.95 Cr ₹60.91 Cr ₹76.82 Cr ₹64.2 Cr ₹66.87 Cr ₹63.85 Cr ₹75.75 Cr ₹82.75 Cr ₹64.45 Cr ₹65.76 Cr ₹64.4 Cr
Purchases of Stock-in-Trade ₹3.1 Cr ₹3.89 Cr ₹4.71 Cr ₹3.2 Cr ₹3.28 Cr ₹3.98 Cr ₹6.51 Cr ₹3.65 Cr ₹3.17 Cr ₹2.22 Cr ₹6.77 Cr ₹3.83 Cr
Changes in Inventories -₹53.58 Lakh ₹4.48 Cr -₹3.75 Cr ₹2 Cr -₹1.22 Cr -₹42.22 Lakh ₹46.7 Lakh -₹3.05 Cr -₹88.92 Lakh ₹7.63 Cr ₹3.84 Cr ₹7.86 Cr
Employee Benefit Expense ₹28.69 Cr ₹26.42 Cr ₹26.31 Cr ₹26.35 Cr ₹25.15 Cr ₹20.14 Cr ₹24.63 Cr ₹21.07 Cr ₹21.08 Cr ₹20.7 Cr ₹19.17 Cr ₹19.62 Cr
Finance Costs ₹7.54 Cr ₹9.04 Cr ₹10.17 Cr ₹10.15 Cr ₹7.59 Cr ₹7.46 Cr ₹8.26 Cr ₹7.67 Cr ₹5.79 Cr ₹7.51 Cr ₹6.63 Cr ₹3.94 Cr
Depreciation & Amortisation ₹3.64 Cr ₹3.37 Cr ₹3.32 Cr ₹3.32 Cr ₹3.29 Cr ₹3.28 Cr ₹3.32 Cr ₹3.24 Cr ₹3.18 Cr ₹3.07 Cr ₹3.13 Cr ₹3.15 Cr
Other Expenses ₹34.71 Cr ₹31.63 Cr ₹31.32 Cr ₹32.81 Cr ₹28.73 Cr ₹30.68 Cr ₹28.89 Cr ₹29.69 Cr ₹26.83 Cr ₹23.82 Cr ₹23.78 Cr ₹22.65 Cr
Total Expenses ₹149.93 Cr ₹154.79 Cr ₹133 Cr ₹154.65 Cr ₹131.02 Cr ₹131.98 Cr ₹135.93 Cr ₹138.03 Cr ₹141.91 Cr ₹129.4 Cr ₹129.08 Cr ₹125.45 Cr
Profit Before Exceptional Items & Tax ₹13.61 Cr ₹19.05 Cr ₹1.29 Cr ₹8.17 Cr ₹1.04 Cr ₹8.35 Cr ₹10.26 Cr ₹7.19 Cr ₹4.99 Cr ₹1.51 Cr -₹3.04 Cr -₹71 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹25.56 Cr ₹0 ₹0 ₹0 -₹59.38 Lakh ₹0 ₹0
Profit Before Tax ₹13.61 Cr ₹19.05 Cr ₹1.29 Cr ₹8.17 Cr ₹1.04 Cr ₹33.91 Cr ₹10.26 Cr ₹7.19 Cr ₹4.99 Cr ₹92.04 Lakh -₹3.04 Cr -₹71 Lakh
Total Tax Expense ₹11.53 Lakh -₹1.2 Cr ₹7.44 Lakh ₹14.86 Lakh ₹0 ₹27.21 Lakh -₹1.72 Lakh -₹17.64 Lakh ₹30.24 Lakh -₹9.52 Lakh ₹23.21 Lakh ₹17.98 Lakh
Net Profit ₹13.49 Cr ₹20.26 Cr ₹1.22 Cr ₹8.02 Cr ₹1.04 Cr ₹33.63 Cr ₹10.27 Cr ₹7.36 Cr ₹4.69 Cr ₹1.02 Cr -₹3.28 Cr -₹88.98 Lakh
  attributable to Owners ₹0 - ₹0 ₹0 ₹0 ₹0 - - - - - -
  attributable to NCI ₹0 - ₹0 ₹0 ₹0 ₹0 - - - - - -
Other Comprehensive Income -₹21.47 Lakh ₹4.66 Lakh -₹13.83 Lakh -₹15.28 Lakh -₹27.26 Lakh -₹52.51 Lakh ₹9.41 Lakh ₹37.17 Lakh -₹65.61 Lakh ₹26.86 Lakh -₹16.24 Lakh -₹38.1 Lakh
Total Comprehensive Income ₹13.28 Cr ₹20.3 Cr ₹1.08 Cr ₹7.87 Cr ₹76.48 Lakh ₹33.11 Cr ₹10.37 Cr ₹7.73 Cr ₹4.03 Cr ₹1.28 Cr -₹3.44 Cr -₹1.27 Cr
EBITDA (computed) ₹24.79 Cr ₹31.47 Cr ₹14.78 Cr ₹21.64 Cr ₹11.92 Cr ₹19.09 Cr ₹21.84 Cr ₹18.1 Cr ₹13.96 Cr ₹12.1 Cr ₹6.72 Cr ₹6.38 Cr
Basic EPS ₹4.12 ₹6.18 ₹0.38 ₹2.44 ₹0.32 ₹2.47 ₹3.13 ₹2.25 ₹1.43 ₹0.49 ₹-1.00 ₹-0.27
Diluted EPS ₹3.95 ₹5.98 ₹0.35 ₹2.34 ₹0.31 ₹2.37 ₹3.13 ₹2.25 ₹1.43 ₹0.49 ₹-1.00 ₹-0.27
Latest 12 quarters shown of 22 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Wanbury Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Wanbury Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 43.02%, foreign institutional investors hold 0.59%, domestic institutional investors hold 0.00%, retail and other public shareholders hold 56.39% of Wanbury Limited. The company had 16,732 shareholders on record.

Promoters: 43.02%FII (Foreign Institutional): 0.59%Retail & Others: 56.39%
Mar 2026
QUARTER
43.02% Promoters
0.59% FII (Foreign Institutional)
56.39% Retail & Others
Promoter holding - history
Now 43.02% · Mar 2026High 56.11% · Feb 2017Low 39.63% · Jun 2025
38%43%48%53%58%Dec 2015Jun 2018Dec 2020Jun 2023Mar 2026Dec 2015: 48.97%Mar 2016: 48.97%Jun 2016: 48.97%Sep 2016: 48.97%Dec 2016: 48.97%Feb 2017: 56.11%Mar 2017: 56.11%Jun 2017: 56.11%Sep 2017: 56.11%Dec 2017: 56.11%Mar 2018: 54.93%Jun 2018: 54.93%Sep 2018: 54.93%Dec 2018: 54.93%Mar 2019: 54.93%Jun 2019: 54.93%Sep 2019: 54.93%Dec 2019: 54.93%Jan 2020: 52.18%Mar 2020: 52.13%Jun 2020: 52.13%Sep 2020: 52.09%Dec 2020: 52.09%Mar 2021: 52.09%Apr 2021: 39.93%Jun 2021: 39.90%Sep 2021: 39.90%Dec 2021: 39.89%Mar 2022: 39.89%Jun 2022: 39.85%Sep 2022: 39.85%Dec 2022: 39.84%Mar 2023: 39.84%Jun 2023: 39.84%Sep 2023: 39.80%Dec 2023: 39.79%Mar 2024: 39.79%Jun 2024: 39.79%Sep 2024: 39.77%Dec 2024: 39.76%Mar 2025: 39.76%Jun 2025: 39.63%Sep 2025: 43.09%Dec 2025: 43.07%Mar 2026: 43.02%56.11%39.63%43.02%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters43.02%43.07%43.09%39.63%39.76%39.76%
Public56.98%56.93%56.91%60.37%60.24%60.24%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Promoters43.02%39.76%39.79%39.84%39.89%52.09%52.13%54.93%54.93%56.11%48.97%
Public56.98%60.24%60.21%60.16%60.11%47.91%47.87%45.07%45.07%43.89%51.03%
Promoter change (YoY, %pts)+3.26-0.03-0.05-0.05-12.20-0.04-2.80+0.00-1.18+7.14-

Board & Governance of Wanbury Limited

As per the corporate governance filing with NSE for the quarter ended 31-DEC-2025, the board of Wanbury Limited has 6 directors - 4 independent and 2 executive. The board is chaired by CHANDRAN KRISHNAMOORTHY.

DirectorPositionOn board sinceListed boards
CHANDRAN KRISHNAMOORTHY Executive Director · Chairperson 2010-09-01 1
MOHAN KUMAR RAYANA Executive Director 2023-08-21 1
ANUPAMA VAIDYA Non-Executive - Independent Director 2023-03-17 3
MRIDUL SUMANLAL MEHTA Non-Executive - Independent Director 2024-08-12 1
MANOJKUMAR KHUBCHAND GURSAHANI Non-Executive - Independent Director 2025-01-08 1
PALLAVUR SANKAR DASS VAIDYANATHAN Non-Executive - Independent Director 2025-01-08 1
Board Committees
CommitteeMembers
Audit Committee ANUPAMA VAIDYA, CHANDRAN KRISHNAMOORTHY, MRIDUL SUMANLAL MEHTA (Chairperson), MANOJKUMAR KHUBCHAND GURSAHANI, PALLAVUR SANKAR DASS VAIDYANATHAN
Nomination and remuneration committee ANUPAMA VAIDYA (Chairperson), MRIDUL SUMANLAL MEHTA, MANOJKUMAR KHUBCHAND GURSAHANI, PALLAVUR SANKAR DASS VAIDYANATHAN
Stakeholders Relationship Committee MRIDUL SUMANLAL MEHTA (Chairperson), ANUPAMA VAIDYA, CHANDRAN KRISHNAMOORTHY, MANOJKUMAR KHUBCHAND GURSAHANI, PALLAVUR SANKAR DASS VAIDYANATHAN

Charges & Borrowings of Wanbury Limited

Open charges
₹255 Cr
Satisfied charges
₹722.25 Cr
Breakdown by lending institutions
Others₹200.00 Cr
Sbicap Trustee Company Limited₹40.00 Cr
Sbi Global Factors Limited₹15.00 Cr
Latest charge details
DateLenderAmountStatus
27 Feb 2025 Others ₹200 Cr Open
23 Feb 2024 Sbicap Trustee Company Limited ₹40 Cr Open
22 Apr 2014 Sbi Global Factors Limited ₹15 Cr Open
10 Jun 2024 Sbicap Trustee Company Limited ₹60 Cr Satisfied
19 Jul 2023 Sbicap Trustee Company Limited ₹95 Cr Satisfied

Total charge records: 31 View all charges

Employees and EPFO Compliance at Wanbury Limited

Wanbury Limited has a workforce of 742 employees as of Apr 05, 2024.

Employee count
742
Active EPFO establishments
2
Employee growth
-4.26%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Wanbury Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Wanbury Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Wanbury Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Wanbury Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Wanbury Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Wanbury Limited

MSME Payment Delays by Wanbury Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Wanbury Limited

Subsidiaries & Group Companies of Wanbury Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Wanbury Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Wanbury Limited

MCA Filings & Documents of Wanbury Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Wanbury Limited

Charges
09 Oct 2025
A charge with Sbicap Trustee Company Limited of Rs. 40.00 Cr registered on 23 Feb 2024 with Charge ID 100877119 was modified on 09 Oct 2025.
Charges
30 Sep 2025
A charge with Others of Rs. 200.00 Cr registered on 27 Feb 2025 with Charge ID 101084774 was modified on 30 Sep 2025.
Activity
18 Sep 2025
Wanbury Limited last Annual general meeting of members was held on 18 Sep 2025 as per latest MCA records.
Charges
23 Jul 2025
A charge registered on 02 Feb 2010 via Charge ID 10198432 with Sbicap Trustee Company Limited was fully satisfied on 23 Jul 2025.
Charges
23 Jul 2025
A charge registered on 29 Dec 2009 via Charge ID 10203027 with Sbicap Trustee Company Limited was fully satisfied on 23 Jul 2025.
Activity
31 Mar 2025
Wanbury Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.

Recent News on Wanbury Limited

Frequently Asked Questions about Wanbury Limited

Wanbury Limited is an active public limited company in the pharma sector based in New Mumbai, Maharashtra, India. It was incorporated on 11 August 1988 (38+ years old) and is registered under CIN L51900MH1988PLC048455. Listed on BSE: 524212 and NSE: BE : WANBURY. The company has 742 employees.

Wanbury Limited reported revenue of ₹603.01 Cr for FY 2025 (up 4.00% YoY).

The current directors of Wanbury Limited are:

The primary industry of Wanbury Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.

Yes. Wanbury Limited is listed on both BSE (code: 524212) and NSE (symbol: BE : WANBURY).

Wanbury Limited can be reached at the registered office: Bsel Tech Park B; Wing 10Th Floor Sector 30A Opp.Vashi Railway Station V, Ashi, New Mumbai, Maharashtra, India – 400703, or through the website wanbury.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available